All Stories

  1. Determinants of Mortality in Patients With COPD

    Article • CHEST Journal, April 2025, Elsevier

    Dr. Benjamin Waschki

  2. 17q21 Variants Disturb Mucosal Host Defense in Childhood Asthma

    Article • American Review of Respiratory Disease, April 2024, American Thoracic Society

    Dr. Benjamin Waschki

  3. Spatial characteristics of non-communicable diseases and their associations to social conditions in a large urban cohort in Germany—Results from the Hamburg City Health Study

    Article • PLOS One, April 2024, PLOS

    Dr. Benjamin Waschki

  4. Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD—results from COSYCONET

    Article • Respiratory Research, January 2024, Springer Science + Business Media

    Dr. Benjamin Waschki

  5. Hemodynamics and Diastolic Function after Native Aortic Valve Preserving vs. Replacing Surgery

    Article • The Thoracic and Cardiovascular Surgeon, September 2023, Thieme Publishing Group

    Dr. Benjamin Waschki

  6. Validation of the Asthma Severity Scoring System (ASSESS) in the ALLIANCE Cohort

    Article • Journal of Allergy and Clinical Immunology, June 2023, Elsevier

    Dr. Benjamin Waschki

  7. Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS‑CoV‑2 infection: an analysis of the baseline examination of the German COVIDOM/NAPKON-POP cohort

    Article • Infection, May 2023, Springer Science + Business Media

    Dr. Benjamin Waschki

  8. Physical and Mental Recovery after Aortic Valve Surgery in Non-Elderly Patients: Native Valve-Preserving Surgery vs. Prosthetic Valve Replacement

    Article • Journal of Cardiovascular Development and Disease, March 2023, MDPI AG

    Dr. Benjamin Waschki

  9. Cardiovascular predictors of mortality and exacerbations in patients with COPD

    Article • Scientific Reports, December 2022, Springer Science + Business Media

    Dr. Benjamin Waschki

  10. IgA+ memory B cells are significantly increased in patients with asthma and small airways dysfunction

    Article • European Respiratory Journal, May 2022, European Respiratory Society (ERS)

    Dr. Benjamin Waschki

  11. T2-high asthma phenotypes across lifespan

    Article • European Respiratory Journal, February 2022, European Respiratory Society (ERS)

    Dr. Benjamin Waschki

  12. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme

    Article • European Heart Journal, January 2022, Oxford University Press (OUP)

    Dr. Benjamin Waschki

  13. Small Airway Dysfunction Links Asthma Severity with Physical Activity and Symptom Control

    Article • The Journal of Allergy and Clinical Immunology In Practice, September 2021, Elsevier

    Dr. Benjamin Waschki

  14. The Relevance of Small Airway Dysfunction in Asthma with Nocturnal Symptoms

    Article • Journal of Asthma and Allergy, July 2021, Taylor & Francis

    Dr. Benjamin Waschki

  15. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

    Article • The Lancet Respiratory Medicine, May 2021, Elsevier

    Dr. Benjamin Waschki

  16. Persistent Uncontrolled Asthma: Long-Term Impact on Physical Activity and Body Composition

    Article • Journal of Asthma and Allergy, March 2021, Taylor & Francis

    Dr. Benjamin Waschki

  17. Deterioration and Mortality Risk of COPD Patients Not Fitting into Standard GOLD Categories: Results of the COSYCONET Cohort

    Article • Respiration, January 2021, Karger Publishers

    Dr. Benjamin Waschki

  18. Cytokine levels in children and adults with wheezing and asthma show specific patterns of variability over time

    Article • Clinical & Experimental Immunology, December 2020, Oxford University Press (OUP)

    Dr. Benjamin Waschki

  19. <p>Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort</p>

    Article • International Journal of Chronic Obstructive Pulmonary Disease, November 2020, Taylor & Francis

    Dr. Benjamin Waschki

  20. Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma: a longitudinal observational study

    Article • Respiratory Research, October 2020, Springer Science + Business Media

    Dr. Benjamin Waschki

  21. Breath volatile organic compounds and inflammatory markers in adult asthma patients: negative results from the ALLIANCE cohort

    Article • European Respiratory Journal, October 2020, European Respiratory Society (ERS)

    Dr. Benjamin Waschki

  22. Iron deficiency and lung function decline in stable COPD – a prospective cohort study

    Article • September 2020, European Respiratory Society (ERS)

    Dr. Benjamin Waschki

  23. RNA‐seq–based profiling of extracellular vesicles in plasma reveals a potential role of miR‐122‐5p in asthma

    Article • Allergy, July 2020, Wiley

    Dr. Benjamin Waschki

  24. Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: Results from COSYCONET

    Article • Scientific Reports, June 2020, Springer Science + Business Media

    Dr. Benjamin Waschki

  25. The impact of COPD on polyneuropathy: results from the German COPD cohort COSYCONET

    Article • Respiratory Research, January 2020, Springer Science + Business Media

    Dr. Benjamin Waschki

  26. High-sensitivity troponin I and all-cause mortality in patients with stable COPD: an analysis of the COSYCONET study

    Article • European Respiratory Journal, December 2019, European Respiratory Society (ERS)

    Dr. Benjamin Waschki

  27. Time-updated resting heart rate predicts mortality in patients with COPD

    Article • Clinical Research in Cardiology, November 2019, Springer Science + Business Media

    Dr. Benjamin Waschki

  28. The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort

    Article • Respiratory Research, November 2019, Springer Science + Business Media

    Dr. Benjamin Waschki

  29. Rationale and Design of the Hamburg City Health Study

    Article • European Journal of Epidemiology, November 2019, Springer Science + Business Media

    Dr. Benjamin Waschki

  30. CAT score single item analysis in patients with COPD: Results from COSYCONET

    Article • Respiratory Medicine, November 2019, Elsevier

    Dr. Benjamin Waschki

  31. Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort

    Article • International Journal of Chronic Obstructive Pulmonary Disease, September 2019, Taylor & Francis

    robert bals, Claus Vogelmeier, Dr. Benjamin Waschki

  32. Consequences of chronic kidney disease in chronic obstructive pulmonary disease

    Article • Respiratory Research, July 2019, Springer Science + Business Media

    Dr. Benjamin Waschki

  33. Biomarkers and clinical outcomes in COPD: a systematic review and meta-analysis

    Article • Thorax, January 2019, BMJ

    Dr. Benjamin Waschki

  34. Airway obstruction and lung hyperinflation in COPD are linked to an impaired left ventricular diastolic filling

    Article • Respiratory Medicine, April 2018, Elsevier

    Dr. Benjamin Waschki

  35. Neutrophil extracellular trap formation is regulated by CXCR2 in COPD neutrophils

    Article • European Respiratory Journal, February 2018, European Respiratory Society (ERS)

    Prof. Dr. Torsten Goldmann, Dr. Benjamin Waschki

  36. Right Ventricular Index for Risk Stratification of Patients with Pulmonary Arterial Hypertension

    Article • Respiration, January 2018, Karger Publishers

    Dr. Benjamin Waschki

  37. Physical Activity and Fatigue in Patients with Sarcoidosis

    Article • Respiration, November 2017, Karger Publishers

    Dr. Benjamin Waschki

  38. Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis

    Article • BMC Pulmonary Medicine, July 2017, Springer Science + Business Media

    Dr. Benjamin Waschki

  39. Chronisch obstruktive Lungenerkrankung und Komorbiditäten

    Article • Der Pneumologe, July 2017, Springer Science + Business Media

    Dr. Benjamin Waschki

  40. Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function

    Article • International Journal of Chronic Obstructive Pulmonary Disease, March 2017, Dove Medical Press

    Professor Klaus F. Rabe, Dr. Benjamin Waschki

  41. Physical activity patterns and clusters in 1001 patients with COPD

    Article • Chronic Respiratory Disease, February 2017, SAGE Publications

    Dr. Benjamin Waschki

  42. Analysis of nocturnal actigraphic sleep measures in patients with COPD and their association with daytime physical activity

    Article • Thorax, January 2017, BMJ

    Dr. Benjamin Waschki

  43. Physical activity, airway resistance and small airway dysfunction in severe asthma

    Article • European Respiratory Journal, December 2016, European Respiratory Society (ERS)

    Dr. Benjamin Waschki

  44. Angiopoietin-like protein 4 and cardiovascular function in COPD

    Article • BMJ Open Respiratory Research, October 2016, BMJ

    Dr. Benjamin Waschki

  45. Reduced physical activity in lymphangioleiomyomatosis compared with COPD and healthy controls: disease-specific impact and clinical correlates

    Article • Thorax, March 2016, BMJ

    Dr. Benjamin Waschki

  46. Clinical Correlates of Reduced Physical Activity in Idiopathic Pulmonary Fibrosis

    Article • Respiration, January 2016, Karger Publishers

    Dr. Benjamin Waschki

  47. Handgrip weakness and mortality risk in COPD: a multicentre analysis

    Article • Thorax, October 2015, BMJ

    Dr. Benjamin Waschki

  48. Neutrophil extracellular trap formation and extracellular DNA in sputum of stable COPD patients

    Article • Respiratory Medicine, October 2015, Elsevier

    Prof. Dr. Torsten Goldmann, Dr. Benjamin Waschki

  49. Disease Progression and Changes in Physical Activity in Patients with Chronic Obstructive Pulmonary Disease

    Article • American Review of Respiratory Disease, August 2015, American Thoracic Society

    Dr. Benjamin Waschki

  50. An official European Respiratory Society statement on physical activity in COPD

    Article • European Respiratory Journal, October 2014, European Respiratory Society (ERS)

    Professor Enrico M. Clini, Dr. Benjamin Waschki

  51. Potential prognostic value of biomarkers in lavage, sputum and serum in a five year clinical follow-up of smokers with and without COPD

    Article • BMC Pulmonary Medicine, March 2014, Springer Science + Business Media

    Dr. Benjamin Waschki

  52. Systemic Biomarkers of Neutrophilic Inflammation, Tissue Injury and Repair in COPD Patients with Differing Levels of Disease Severity

    Article • PLOS One, June 2012, PLOS

    Dr. Benjamin Waschki

  53. Hyponatremia as prognostic factor in small cell lung cancer – A retrospective single institution analysis

    Article • Respiratory Medicine, June 2012, Elsevier

    Dr. Benjamin Waschki

  54. Physical activity monitoring in COPD: Compliance and associations with clinical characteristics in a multicenter study

    Article • Respiratory Medicine, April 2012, Elsevier

    Dr. Benjamin Waschki

  55. Physical Activity Is the Strongest Predictor of All-Cause Mortality in Patients With COPD

    Article • CHEST Journal, August 2011, Elsevier

    Dr. Benjamin Waschki

  56. Characteristics, treatment patterns and outcomes of patients with small cell lung cancer—A retrospective single institution analysis

    Article • Lung Cancer, March 2011, Elsevier

    Dr. Benjamin Waschki

  57. Vergleich von Behandlungsergebnissen in zwei Patientengruppen (2004–2005 und 2007–2008) mit einem kleinzelligen Bronchialkarzinom im begrenzten und metastasierten Krankheitsstadium

    Article • Pneumologie, January 2011, Thieme Publishing Group

    Dr. Benjamin Waschki

  58. Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer – A retrospective single institution analysis

    Article • Respiratory Medicine, December 2010, Elsevier

    Dr. Benjamin Waschki

  59. "PHYSICAL ACTIVITY IN PATIENTS WITH COPD". H. WATZ, B. WASCHKI, T. MEYER AND H. MAGNUSSEN. EUR RESPIR J 2009; 33: 262-272.

    Article • European Respiratory Journal, July 2010, European Respiratory Society (ERS)

    Dr. Benjamin Waschki

  60. Decreasing Cardiac Chamber Sizes and Associated Heart Dysfunction in COPD

    Article • CHEST Journal, July 2010, Elsevier

    Dr. Benjamin Waschki

  61. Emphysema, Airflow Obstruction, and Left Ventricular Filling

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, April 2010, New England Journal of Medicine (NEJM/MMS)

    Dr. Benjamin Waschki

  62. Metabolic Syndrome and Impaired Lung Function: Response

    Article • CHEST Journal, February 2010, Elsevier

    Dr. Benjamin Waschki

  63. The Metabolic Syndrome in Patients With Chronic Bronchitis and COPD

    Article • CHEST Journal, October 2009, Elsevier

    Dr. Benjamin Waschki

  64. Die Messung der körperlichen Aktivität von Patienten mit chronisch-obstruktiver Bronchitis und Lungenemphysem

    Article • Medizinische Klinik, April 2009, Springer Science + Business Media

    Dr. Benjamin Waschki

  65. Physical activity in patients with COPD

    Article • European Respiratory Journal, September 2008, European Respiratory Society (ERS)

    Dr. Benjamin Waschki

  66. Extrapulmonary Effects of Chronic Obstructive Pulmonary Disease on Physical Activity

    Article • American Review of Respiratory Disease, April 2008, American Thoracic Society

    Dr. Benjamin Waschki

  67. Herzinsuffizienz bei chronisch-obstruktiver Lungenerkrankung (COPD)

    Article • DMW - Deutsche Medizinische Wochenschrift, April 2008, Thieme Publishing Group

    Dr. Benjamin Waschki